229 related articles for article (PubMed ID: 22101459)
21. Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/β-catenin pathway.
Hung TH; Hsu SC; Cheng CY; Choo KB; Tseng CP; Chen TC; Lan YW; Huang TT; Lai HC; Chen CM; Chong KY
Oncotarget; 2014 Dec; 5(23):12273-90. PubMed ID: 25401518
[TBL] [Abstract][Full Text] [Related]
22. Wnt5a promotes ewing sarcoma cell migration through upregulating CXCR4 expression.
Jin Z; Zhao C; Han X; Han Y
BMC Cancer; 2012 Oct; 12():480. PubMed ID: 23075330
[TBL] [Abstract][Full Text] [Related]
23. WNT5A is a key regulator of the epithelial-mesenchymal transition and cancer stem cell properties in human gastric carcinoma cells.
Kanzawa M; Semba S; Hara S; Itoh T; Yokozaki H
Pathobiology; 2013; 80(5):235-44. PubMed ID: 23615002
[TBL] [Abstract][Full Text] [Related]
24. Regulation of prostate cancer cell migration toward bone marrow stromal cell-conditioned medium by Wnt5a signaling.
Jin F; Qu X; Fan Q; Wang L; Tang T; Hao Y; Dai K
Mol Med Rep; 2013 Nov; 8(5):1486-92. PubMed ID: 24064566
[TBL] [Abstract][Full Text] [Related]
25. Wnt5a: its signalling, functions and implication in diseases.
Kikuchi A; Yamamoto H; Sato A; Matsumoto S
Acta Physiol (Oxf); 2012 Jan; 204(1):17-33. PubMed ID: 21518267
[TBL] [Abstract][Full Text] [Related]
26. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
[TBL] [Abstract][Full Text] [Related]
27. Wnt5a signaling controls cytokinesis by correctly positioning ESCRT-III at the midbody.
Fumoto K; Kikuchi K; Gon H; Kikuchi A
J Cell Sci; 2012 Oct; 125(Pt 20):4822-32. PubMed ID: 22825874
[TBL] [Abstract][Full Text] [Related]
28. WNT5A inhibits hepatocyte proliferation and concludes β-catenin signaling in liver regeneration.
Yang J; Cusimano A; Monga JK; Preziosi ME; Pullara F; Calero G; Lang R; Yamaguchi TP; Nejak-Bowen KN; Monga SP
Am J Pathol; 2015 Aug; 185(8):2194-205. PubMed ID: 26100214
[TBL] [Abstract][Full Text] [Related]
29. The Wnt-5a-derived hexapeptide Foxy-5 inhibits breast cancer metastasis in vivo by targeting cell motility.
Säfholm A; Tuomela J; Rosenkvist J; Dejmek J; Härkönen P; Andersson T
Clin Cancer Res; 2008 Oct; 14(20):6556-63. PubMed ID: 18927296
[TBL] [Abstract][Full Text] [Related]
30. Wnt/β-Catenin and Wnt5a/Ca Pathways Regulate Proliferation and Apoptosis of Keratinocytes in Psoriasis Lesions.
Zhang Y; Tu C; Zhang D; Zheng Y; Peng Z; Feng Y; Xiao S; Li Z
Cell Physiol Biochem; 2015; 36(5):1890-902. PubMed ID: 26202350
[TBL] [Abstract][Full Text] [Related]
31. IL-1β mediates MCP-1 induction by Wnt5a in gastric cancer cells.
Li S; Wang W; Zhang N; Ma T; Zhao C
BMC Cancer; 2014 Jul; 14():480. PubMed ID: 24993819
[TBL] [Abstract][Full Text] [Related]
32. EGF-reduced Wnt5a transcription induces epithelial-mesenchymal transition via Arf6-ERK signaling in gastric cancer cells.
Zhang Y; Du J; Zheng J; Liu J; Xu R; Shen T; Zhu Y; Chang J; Wang H; Zhang Z; Meng F; Wang Y; Chen Y; Xu Y; Gu L
Oncotarget; 2015 Mar; 6(9):7244-61. PubMed ID: 25779663
[TBL] [Abstract][Full Text] [Related]
33. Wnt5a signaling induces proliferation and survival of endothelial cells in vitro and expression of MMP-1 and Tie-2.
Masckauchán TN; Agalliu D; Vorontchikhina M; Ahn A; Parmalee NL; Li CM; Khoo A; Tycko B; Brown AM; Kitajewski J
Mol Biol Cell; 2006 Dec; 17(12):5163-72. PubMed ID: 17035633
[TBL] [Abstract][Full Text] [Related]
34. Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation.
Yu J; Chen L; Cui B; Widhopf GF; Shen Z; Wu R; Zhang L; Zhang S; Briggs SP; Kipps TJ
J Clin Invest; 2016 Feb; 126(2):585-98. PubMed ID: 26690702
[TBL] [Abstract][Full Text] [Related]
35. Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion.
Kurayoshi M; Oue N; Yamamoto H; Kishida M; Inoue A; Asahara T; Yasui W; Kikuchi A
Cancer Res; 2006 Nov; 66(21):10439-48. PubMed ID: 17079465
[TBL] [Abstract][Full Text] [Related]
36. Wnt5a suppresses colon cancer by inhibiting cell proliferation and epithelial-mesenchymal transition.
Cheng R; Sun B; Liu Z; Zhao X; Qi L; Li Y; Gu Q
J Cell Physiol; 2014 Dec; 229(12):1908-17. PubMed ID: 24464650
[TBL] [Abstract][Full Text] [Related]
37. miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway.
Hu Y; Ou Y; Wu K; Chen Y; Sun W
Tumour Biol; 2012 Dec; 33(6):1863-70. PubMed ID: 23070684
[TBL] [Abstract][Full Text] [Related]
38. WNT5A induces release of exosomes containing pro-angiogenic and immunosuppressive factors from malignant melanoma cells.
Ekström EJ; Bergenfelz C; von Bülow V; Serifler F; Carlemalm E; Jönsson G; Andersson T; Leandersson K
Mol Cancer; 2014 Apr; 13():88. PubMed ID: 24766647
[TBL] [Abstract][Full Text] [Related]
39. Suppression of Frizzled-2-mediated Wnt/Ca²⁺ signaling significantly attenuates intracellular calcium accumulation in vitro and in a rat model of traumatic brain injury.
Niu LJ; Xu RX; Zhang P; Du MX; Jiang XD
Neuroscience; 2012 Jun; 213():19-28. PubMed ID: 22521824
[TBL] [Abstract][Full Text] [Related]
40. The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition.
Dissanayake SK; Wade M; Johnson CE; O'Connell MP; Leotlela PD; French AD; Shah KV; Hewitt KJ; Rosenthal DT; Indig FE; Jiang Y; Nickoloff BJ; Taub DD; Trent JM; Moon RT; Bittner M; Weeraratna AT
J Biol Chem; 2007 Jun; 282(23):17259-71. PubMed ID: 17426020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
